CRISPR Therapeutics
CRSP
#3591
Rank
$3.91 B
Marketcap
$40.37
Share price
-4.43%
Change (1 day)
-27.02%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): -$4.74

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.74. In 2025 the company made an earnings per share (EPS) of -$6.52 a decrease over its 2024 EPS that were of -$4.37.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$4.74-27.3%
2025-$6.5249.2%
2024-$4.37
2022-$8.37-267.74%
2021$4.99
2019$1.11-132.36%
2018-$3.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-$1.35-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA